CompletedPhase 4

Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)

Belgium14 participantsStarted 2010-02-16

Plain-language summary

We will investigate the process of vitiligo induction and the influence of different commonly used cream treatments on this process. Studies comparing different treatments for vitiligo in the induction stage of the disease are still missing. The study hypothesis = cream treatment can stop actively spreading vitiligo lesions during the early induction stage of the disease.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female, * Age 18-70 years, * Extensive vitiligo (\> 50% body surface area), * Patients asking for depigmenting therapy, * Not pregnant. Exclusion Criteria: * Children, * Non extensive vitiligo (\< 50% boy surface area), * Patients not asking for depigmenting therapies, * Pregnant.

What they're measuring

percentage of skin pigmentation in the treated area

Timeframe: after 1 day, 10 days, 30 days and 60 days

Trial details

NCT IDNCT01082393

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-09-15

View on ClinicalTrials.gov More Vitiligo trials